Glioblastoma

Glioblastoma multiforme (GBM) is the most common and most aggressive malignant primary brain tumor in humans, involving glial cells and accounting for 52% of all functional tissue brain tumor cases and 20% of all intracranial tumors. Despite being the most prevalent form of primary brain tumor, GBMs occur in only 2–3 cases per 100,000 people in Europe and North America. According to the WHO classification of the tumors of the central nervous system‎, the standard name for this brain tumor is "glioblastoma"; it presents two variants: giant cell glioblastoma and gliosarcoma. Glioblastomas are also an important brain tumor in canines, and research continues to use this as a model for developing treatments in humans.

Treatment can involve chemotherapy, radiation, radiosurgery, corticosteroids, antiangiogenic therapy, surgery and experimental approaches such as gene transfer.

With the exception of the brainstem gliomas, glioblastoma has the worst prognosis of any central nervous system (CNS) malignancy, despite multimodality treatment consisting of open craniotomy with surgical resection of as much of the tumor as possible, followed by concurrent or sequential chemoradiotherapy, antiangiogenic therapy with bevacizumab, gamma knife radiosurgery, and symptomatic management with corticosteroids. Prognosis is poor, with a median survival time of approximately 14 months.

This text uses material from Wikipedia licensed under CC BY-SA

Latest Spotlight News

Why the lights don't dim when we blink

Every few seconds, our eyelids automatically shutter and our eyeballs roll back in their sockets. So why doesn't blinking plunge us into intermittent darkness and light? New research led by the University of California, Berkeley, ...

What causes sleepiness when sickness strikes

It's well known that humans and other animals are fatigued and sleepy when sick, but it's a microscopic roundworm that's providing an explanation of how that occurs, according to a study from researchers at the Perelman School ...

Curb your immune enthusiasm

Normally when we think of viruses, from the common cold to HIV, we want to boost people's immunity to fight them. But for scientists who develop therapeutic viruses (to, for example, target cancer cells or correct gene deficiencies) ...

In Alzheimer's, excess tau protein damages brain's GPS

Columbia University Medical Center (CUMC) researchers have discovered that the spatial disorientation that leads to wandering in many Alzheimer's disease patients is caused by the accumulation of tau protein in navigational ...

$460-mn vaccine push to 'outsmart' viruses

With the world still reeling from outbreaks of deadly Ebola and baby-deforming Zika, governments and charities launched a $460-million (431 million-euro) initiative Thursday to "outsmart" infectious epidemics.

The great unknown—risk-taking behaviour in adolescents

Adolescents are more likely to ignore information that could prompt them to rethink risky decisions. This may explain why information campaigns on risky behaviors such as drug abuse tend to have only limited success. These ...